Recently, NQO1 overexpression was reported to be a potent independent biomarker for prognostic evaluation of HCC (13) and enhanced apoptosis inhibition of liver cancer cells via the SIRT6/AKT/XIAP signaling pathway (14, 15). Here, NQO1 is linked to liver cancer.